|
Champions Biotechnology, Inc. - Company Profile Snapshot
| Company Profile: |
Champions Biotechnology, Inc. |
| Ticker: |
CSBR |
| Exchanges: |
OTC |
| 2009 Sales: |
3,710,000 |
| Major Industry: |
Recreation |
| Sub Industry: |
Restaurants & Fast Food Franchisers |
| Country: |
UNITED STATES |
| Employees: |
11 |
Business Description
Champions Biotechnology, Inc. Formerly known as Champions Sports, Inc.. The Group's principal activity is engaging in the development of advanced preclinical platforms and predictive tumor specific data to enhance and accelerate the value of oncology drugs. Its preclinical platform is a novel approach based upon the implementation of primary human tumors in immune deficient mice followed by propagation of the resulting xenografts (Biomerk Tumorgrafts) in a manner that preserves the biological characteristics of the original human tumor. It operates in the United States.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
